Annual ROE
-114.18%
-58.57%-105.32%
31 December 2023
Summary:
Moleculin Biotech annual return on equity is currently -114.18%, with the most recent change of -58.57% (-105.32%) on 31 December 2023. During the last 3 years, it has fallen by -94.06% (-467.50%). MBRX annual ROE is now -467.50% below its all-time high of -20.12%, reached on 31 December 2021.MBRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-165.56%
-65.40%-65.30%
30 September 2024
Summary:
Moleculin Biotech quarterly return on equity is currently -165.56%, with the most recent change of -65.40% (-65.30%) on 30 September 2024. Over the past year, it has dropped by -84.65% (-104.62%). MBRX quarterly ROE is now -443.27% below its all-time high of 48.23%, reached on 31 March 2016.MBRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MBRX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -104.6% |
| 3 y3 years | -467.5% | -768.6% |
| 5 y5 years | -34.6% | -123.6% |
MBRX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -467.5% | at low | -768.6% | at low |
| 5 y | 5 years | -467.5% | at low | -768.6% | at low |
| alltime | all time | -467.5% | at low | -443.3% | at low |
Moleculin Biotech ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -165.56%(+65.3%) |
| June 2024 | - | -100.16%(+14.9%) |
| Mar 2024 | - | -87.19%(+7.8%) |
| Dec 2023 | -114.18%(+105.3%) | -80.91%(+33.4%) |
| Sept 2023 | - | -60.64%(+1.8%) |
| June 2023 | - | -59.57%(+10.3%) |
| Mar 2023 | - | -54.03%(+16.2%) |
| Dec 2022 | -55.61%(+176.4%) | -46.51%(+28.2%) |
| Sept 2022 | - | -36.29%(+30.3%) |
| June 2022 | - | -27.86%(+20.8%) |
| Mar 2022 | - | -23.07%(+21.0%) |
| Dec 2021 | -20.12%(-79.4%) | -19.06%(-17.4%) |
| Sept 2021 | - | -23.08%(-19.5%) |
| June 2021 | - | -28.67%(-52.5%) |
| Mar 2021 | - | -60.40%(-45.1%) |
| Dec 2020 | -97.72% | -109.93%(-9.5%) |
| Sept 2020 | - | -121.48%(+3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | -117.70%(+104.1%) |
| Mar 2020 | - | -57.68%(-22.1%) |
| Dec 2019 | -84.81%(+1.9%) | -74.05%(+6.3%) |
| Sept 2019 | - | -69.65%(+14.0%) |
| June 2019 | - | -61.11%(-33.7%) |
| Mar 2019 | - | -92.23%(+29.2%) |
| Dec 2018 | -83.21%(+45.3%) | -71.37%(+0.9%) |
| Sept 2018 | - | -70.75%(-1.3%) |
| June 2018 | - | -71.71%(+18.9%) |
| Mar 2018 | - | -60.32%(+9.5%) |
| Dec 2017 | -57.28%(+118.3%) | -55.09%(+18.2%) |
| Sept 2017 | - | -46.61%(+17.5%) |
| June 2017 | - | -39.68%(+63.3%) |
| Mar 2017 | - | -24.30%(-26.1%) |
| Dec 2016 | -26.24% | -32.89%(+43.6%) |
| Sept 2016 | - | -22.90%(+76.8%) |
| June 2016 | - | -12.95%(-126.9%) |
| Mar 2016 | - | 48.23% |
FAQ
- What is Moleculin Biotech annual return on equity?
- What is the all time high annual ROE for Moleculin Biotech?
- What is Moleculin Biotech quarterly return on equity?
- What is the all time high quarterly ROE for Moleculin Biotech?
- What is Moleculin Biotech quarterly ROE year-on-year change?
What is Moleculin Biotech annual return on equity?
The current annual ROE of MBRX is -114.18%
What is the all time high annual ROE for Moleculin Biotech?
Moleculin Biotech all-time high annual return on equity is -20.12%
What is Moleculin Biotech quarterly return on equity?
The current quarterly ROE of MBRX is -165.56%
What is the all time high quarterly ROE for Moleculin Biotech?
Moleculin Biotech all-time high quarterly return on equity is 48.23%
What is Moleculin Biotech quarterly ROE year-on-year change?
Over the past year, MBRX quarterly return on equity has changed by -84.65% (-104.62%)